LifeRaft Biosciences Revenue
Biotechnology Research • • 1-10 Employees
LifeRaft Biosciences revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at LifeRaft Biosciences
David Waters
Chairman Of The Board Of Directors
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
LifeRaft Biosciences Email Formats
LifeRaft Biosciences uses 1 email format. The most common is {first name} (e.g., john@liferaftbiosciences.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@liferaftbiosciences.com | 100% |
About LifeRaft Biosciences
Liferaft Biosciences is leveraging 50 years of scientific research to redefine approaches to cancer patient treatment, health and wellness. With LifeRaft Biosciences at the forefront of innovation in cancer care -- leading the way with Vepoloxamer in head and neck cancer treatment -- patients can look forward to a future where the adverse effects of radiation therapy are minimized, and the promise of improved treatment outcomes becomes a reality. Partner with us for ongoing research and clinical trials to extend the benefits of Vepoloxamer to head and neck and lung cancer patients, lessen the impact of radiotherapy-induced toxicities and improve patients’ quality of life during and after treatment.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
LifeRaft Biosciences has never raised funding before.
Germany
United Kingdom
Norway
SpainFrequently asked questions
4.8
40,000 users
